Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Angiotensin-(1-7) and Energy Expenditure in Human Obesity
NCT03777215Phase 1Completed
- Start
- Sep 2019
- Primary completion
- Apr 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in obesity comparing Angiotensin-(1-7) with Placebo (2 arms). Primary endpoints: Resting energy expenditure at 120 minutes and Uncoupling protein 1 at 120 minutes. Started Sep 2019; status: completed.
02
Drugs
angiotensin-(1-7)
03
Conditions
obesity
Beyond the preview
Go deeper on NCT03777215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03777215.